Next 10 |
2024-07-10 13:06:15 ET UBS analysts updated their "global top list." Leadership among stocks once again narrowed in June, with info technology ( XLK ) keeping its top seat among the sectors. ... Read the full article on Seeking Alpha For further details see: Update o...
2024-07-08 10:28:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medical device stocks are effectively redefining the healthcare industry through innovative technology. The digitization trend in healthcare continues gaining steam, with advanced medical d...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
2024-07-03 11:27:26 ET Summary DexCom presented outlook on diabetes market at the ADA Conference, highlighting potential for growth with new products like Stelo and DexCom ONE. DexCom's strategy differs from Abbott Labs, focusing on OTC CGM products like Stelo to expand target mar...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...
2024-06-24 12:06:59 ET More on DexCom, Tandem Diabetes Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here Dexcom: Positive Catalysts Ahead To Support Growth DexCom: Attractive Discount After Strong Earnings Results Tandem Diabetes Care...
2024-06-21 08:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Searching for the next addition to your portfolio makes it easy to get caught up in the excitement surrounding the latest Wall Street darlings. Yet, not all hyped stocks have promising prospect...
2024-06-20 10:12:35 ET More on DexCom Dexcom: Positive Catalysts Ahead To Support Growth DexCom: Attractive Discount After Strong Earnings Results DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript DexCom, Insulet, Tandem seen benefitting the most in diabet...
The world’s most connected continuous glucose monitoring system ‡ , Dexcom G6, now connects with the Omnipod® 5 Automated Insulin Delivery (AID) System in The Netherlands. DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring fo...
Dexcom unveils more clinical data reaffirming the benefits of Dexcom CGM use among people with Type 2 diabetes than at any previous ADA conference. ADA conference presentations reiterate the advantages of Dexcom CGM use alongside incretin therapies such as GLP-1s. 1,2 New Dexc...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...